搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 小时
on MSN
Ozempic boasts surprising mental health benefits for teens with obesity: new research
This research contradicts previous concerns about the potential of drugs like Ozempic to trigger suicidal ideation and ...
1 小时
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
3FM Isle of Man
12 小时
Don't use Ozempic or Wegovy for 'Instagram perfect body', says health secretary
Weight loss jabs like Ozempic and Wegovy should not be used to get the Instagram perfect body, Wes Streeting said amid a ...
4 天
on MSN
France won’t pay for weight loss drug Wegovy. What about other European countries?
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...
4 天
Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...
自行车网
11 天
被滥用的“减肥神药”司美格鲁肽,会出现在自行车赛场吗?
近年来兴起的新型减肥药,例如Ozempic和Wegovy,已经帮助全世界的人们减掉了超过15%的体重,它的作用之夸张,以至于沃尔玛将食品销量的下降归因于这些药物的发明和上市。因此,许多人将这种新一代药物称为社会的“游戏规则改变者”。
23 小时
on MSN
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...
13 天
诺和诺德股票前景修正:定价压力影响Wegovy和Ozempic销售增长
周三,美银证券调整了对诺和诺德公司(NYSE:NVO)股票的展望,将目标价从之前的166.00美元下调至159.50美元,同时维持对该股票的买入评级。这一调整是因为分析师预计第三季度集团销售额将达到约694亿丹麦克朗,同比增长18%,息税前利润(EBIT)将达到约330亿丹麦克朗,较上年同期增长23%。尽管有这些增长,预测的EBIT比共识预期低约4%。
1 天
Thousands of people with life-threatening obesity denied access to weight-loss jab Wegovy
Doctors have said access to the drug is a "postcode lottery" as Sky News analysis reveals just 800 people have been ...
1 天
on MSN
Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
16 小时
on MSN
Report: US calorie intake may reduce by trillions by 2030, grocery sales report says
A surge in the use of GLP-1 drugs is among the reasons a new report projects a calorie intake decline of 10 quadrillion in U.S. adults by 2030.
7 天
诺和诺德就减肥药Ozempic和Wegovy专利纠纷与迈兰制药达成和解
诺和诺德与Viatris旗下迈兰制药在一份联合文件中表示,已同意解决与诺和诺德减肥药Ozempic和Wegovy相关的专利纠纷。此前诺和诺德已分别在法院起诉Viatris和其他公司侵犯专利,以阻止拟议的仿制药。诺和诺德发言人当地时间10月7日证实了和解协议。
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈